Loading insider details...
Beta
Latest Form 4 (Aug 18, 2026): Grant/Award of 102,040 DRMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 102,040 | n/a |
| Jan 7, 2026 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 18,000 | n/a |
| Dec 30, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 122,549 | n/a |
| Jan 23, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 78,741 | n/a |
| Jan 14, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 20,000 | n/a |
| Jan 5, 2024 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 50,000 | n/a |
| Jan 5, 2023 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 100,000 | n/a |
| Jan 6, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 30,000 | n/a |
| Sep 2, 2021 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 75,000 | n/a |